Search information pages
About Longevity & Healthspan
This page includes information about the aims and scope of Longevity & Healthspan, editorial policies, open access and article-processing charges, the peer review process and other information. For details of how to prepare and submit a manuscript through the online submission system, please see the instructions for authors.
Aims & scope
Longevity & Healthspan is an open access, peer-reviewed, interdisciplinary journal that publishes articles on all aspects of aging biology in the context of healthy aging or age-related disease. More specifically, the journal emphasizes advancing understanding of how age-related changes in structure and function become risk factors for or accompany age-related diseases or conditions, and the biology underlying healthy aging and longevity.
Experimental approaches include biochemistry, molecular genetics, genome-wide association studies, cell biology, and interventional studies.
The journal welcomes articles in particular in the following areas:
- Development of criteria to define successful aging in humans or model organisms
- Development of genetically tractable animal models assessing healthspan or age-related conditions
- Interdisciplinary studies involving both aging and age-related disease specialists
- Studies of candidate genes or pathways that correlate with age-related conditions
- Studies on the biology of healthy aging and longevity
- Translational studies validating interventions to increase healthspan and/or longevity
Epidemiological studies and studies of interventions targeting age-related conditions with concurrent study of other age-associated end points will also be given consideration.
Aging represents the most important risk factor for chronic disease, frailty, and loss of independence, making an understanding of the mechanisms by which aging curtails healthspan and leads to disease highly desirable from both a social and economic standpoint. Longevity & Healthspan bridges the gap between research on the basic biology of aging and clinical dysfunction associated with the aging process.
All articles published by Longevity & Healthspan are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.
Authors of articles published in Longevity & Healthspan are the copyright holders of their articles and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate the article, according to the BioMed Central copyright and license agreement.
For authors who are US government employees or are prevented from being copyright holders for similar reasons, BioMed Central can accommodate non-standard copyright lines. Please contact us if further information is needed.
Open access publishing is not without costs. Longevity & Healthspan therefore levies an article-processing charge of £1475/$2410/€1775 for each article accepted for publication. We routinely waive charges for authors from low-income countries. Generally, if the submitting author's institution is a Member the cost of the article-processing charge is covered by the membership, and no further charge is payable. In the case of authors whose institutions are Supporter Members, however, a discounted article-processing charge is payable by the author. For further details, see our article-processing charge page. A limited number of waivers for article-processing charges are also available at the editors' discretion, and authors wishing to apply for these waivers should contact the editors.
All articles published in Longevity & Healthspan are included in:
- PubMed Central
BioMed Central is working closely with Thomson Reuters (ISI) to ensure that citation analysis of articles published in Longevity & Healthspan will be available.
Publication and peer review process
Authors will be able to check the progress of their manuscript through the submission system at any time by logging into My Longevity & Healthspan, a personalized section of the site.
Copyediting and proofs
Longevity & Healthspan will copyedit manuscripts before they are published.
Following the acceptance of an article, it is published in Longevity & Healthspan as a provisional PDF file with minimal delay (subject to formatting checks, copyediting and author verification). Fully formatted PDF and full-text (HTML) versions are made available shortly after that.
High-quality, bound reprints can be purchased for all articles published. Please see our reprints website for further information about ordering reprints.
Longevity & Healthspan will consider supplements based on proceedings (full articles or meeting abstracts), reviews or research. All articles submitted for publication in supplements are subject to peer review. Published supplements are fully searchable and freely accessible online and can also be produced in print. For further information, please contact us.
All manuscripts submitted to Longevity & Healthspan should adhere to BioMed Central's editorial policies.
Citing articles in Longevity & Healthspan
Articles in Longevity & Healthspan should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.
Article citations follow this format:
Authors: Title. Longevity Healthspan [year], [volume number]:[article number].
e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. Longevity Healthspan 2009, 1:115.
refers to article 115 from Volume 1 of the journal.
Why publish your article in Longevity & Healthspan?
Longevity & Healthspan's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience. Articles that have been especially highly accessed are highlighted with a 'Highly accessed' graphic, which appears on the journal's contents pages and search results.
Speed of publication
Longevity & Healthspan offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles are published with their final citation immediately upon acceptance in a provisional PDF form. The article will subsequently be published in both fully browsable web form, and as a formatted PDF; the article will then be available through Longevity & Healthspan and BioMed Central.
Online publication in Longevity & Healthspan gives authors the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).
Promotion and press coverage
Articles published in Longevity & Healthspan are included in article alerts and regular email updates. Some may be included in abstract books mailed to academics and are highlighted on Longevity & Healthspan's pages and on the BioMed Central homepage.
In addition, articles published in Longevity & Healthspan may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in Longevity & Healthspan. A list of articles recently press-released by journals published by BioMed Central is available here.
Authors of articles published in Longevity & Healthspan retain the copyright of their articles and are free to reproduce and disseminate their work (for further details, see the BioMed Central copyright and license agreement).
For further information about the advantages of publishing in a journal from BioMed Central, please click here.